I think we all knew a CR was coming. It is just such a shame it came at the multi-year low. However, while we have a lot to complain about with delays, etc, managing capital is certainly not one.
Still less than 150 m shares on issue. Remarkable considering what R&D has been completed and the number of years to get there. Also extremely tightly held, so any upside should be quick, and hopefully large.
My FB feed is full of ads for the PromarkerD, with some having thousands of views. A little hard to spruik the orhers until they are commercialised.
Speaking of which....the clock is ticking management! Eso was promised last quarter and Endo this. Now both have been pushed back. D has still only been released in WA? Was meant to be Australia and the US.
Delays and lack of substantial updates = a crappy SP wih little buyer interest.
I'm still excited about the mid to long term, but now have the rose goggles off and am much more aware of the risk management poses in not taking full advantage of such game changing products.
Milesy
PIQ Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)